Trexquant Investment’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Trexquant Investment’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-49,529	Closed	-$616K	–	1487
2016 Q4	$616K	Sell	49,529 -3,971	-7%	-$47.8K	0.1%	352
2016 Q3	$732K	Sell	53,500 -62,058	-54%	-$623K	0.16%	199
2016 Q2	$854K	Buy	+115,558	New	+$867K	0.11%	288
2016 Q1	–	Sell	-76,426	Closed	-$478K	–	1347
2015 Q4	$478K	Buy	+76,426	New	+$502K	0.04%	700
2015 Q3	–	Sell	-82,408	Closed	-$681K	–	1436
2015 Q2	$681K	Buy	+82,408	New	+$729K	0.08%	497
2015 Q1	–	Sell	-149,200	Closed	-$1.02M	–	1331
2014 Q4	$1.02M	Buy	+149,200	New	+$933K	0.18%	153

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Trexquant Investment's ARIA Position: Q1 2017 in Review

Trexquant Investment sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 49,529 shares — an estimated $616K sold.

Trexquant Investment first reported a position in ARIA in Q4 2014 and held it in 6 quarters. The position peaked at $1.02M in Q4 2014. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Trexquant Investment reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Trexquant Investment sold 49,529 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $616K.
Trexquant Investment first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 6 quarters.
Trexquant Investment's Ariad Pharmaceuticals Inc position peaked at $1.02M in Q4 2014.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Trexquant Investment's 13F filing for Q1 2017, filed 9 May 2017.